BioStem is dedicated to the relentless pursuit of healing through our commitment to innovation and quality.
Since 2014, BioStem Technologies, Inc. has been a leading biomedical innovator, trusted by clinicians across specialties to deliver best-in-class solutions for advanced Surgical Care and advanced Wound Care. We’re passionate about boldly advancing innovation while upholding the principles of good stewardship that have led to us to where we are today, delivering high quality placental allograft products that inspire confidence in our clinicians and partners and help patients improve their lives.
NEWS & EVENTS:
BIOSTEM IN THE NEWS
Don’t miss an opportunity to catch up with the latest developments in advanced Wound Care and Surgical Care.
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
BioStem Technologies Reports First Quarter 2026 Financial Results
BioStem Technologies to Present at the 16th Annual LD Micro Invitational
MKTG-047v01